Keynote review: Intestinal Peyer's patch M cells and oral vaccine targeting

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554

Mucosal immunity and vaccines

Holmgren, J. R., & Czerkinsky, C. C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,559

Veterinary Immunology: An Introduction (2000)

(2001) · Journal of Equine Veterinary Science · doi:10.1016/s0737-0806(01)70088-3 · Cited by 914

Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.

Jones, B. D., Ghori, N., & Falkow, S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.1.15 · Cited by 883

Epithelial Cell Specialization within Human Peyer's Patches: An Ultrastructural Study of Intestinal Lymphoid Follicles

Owen, R. L., & Jones, A. L. (1974) · Gastroenterology · doi:10.1016/s0016-5085(74)80102-2 · Cited by 767

NALT- versus PEYER'S-patch-mediated mucosal immunity

Kiyono, H., & Fukuyama, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1439 · Cited by 745

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics

Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00152-1 · Cited by 682

Conversion by Peyer's Patch Lymphocytes of Human Enterocytes into M Cells that Transport Bacteria

Kernéis, S. M., Bogdanova, A. A., Kraehenbühl, J.-P., & Pringault, E. (1997) · Science · doi:10.1126/science.277.5328.949 · Cited by 630

Vaccines: past, present and future

Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 597

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

Jiang, W., Rk, G., DESHPANDE, M., & Schwendeman, S. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 480

Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach

des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305

Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals

Homayun, B., Lin, X., & Choi, H.-J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030129 · Cited by 837

Advances in Oral Drug Delivery

Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 945

Formulation, stabilisation and encapsulation of bacteriophage for phage therapy

Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594

Is the oral route possible for peptide and protein drug delivery?

Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515

Current challenges in non-invasive insulin delivery systems: A comparative review

Khafagy, E., Morishita, M., Onuki, Y., & Takayama, K. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.019 · Cited by 441

Current state and challenges in developing oral vaccines

Ramirez, J. E. V., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 425

Oral delivery of proteins and peptides: Challenges, status quo and future perspectives

Zhu, Q., Chen, Z., Paul, P. K., Lü, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 366

A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives

Muheem, A., Shakeel, F., Jahangir, M. A., Anwar, M., Mallick, N., Jain, G. K., Warsi, M. H., & Ahmad, F. J. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2014.06.004 · Cited by 343

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331

M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis

Corr, S. C., Gahan, C. C. G. M., & Hill, C. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00359.x · Cited by 320

Biopharmaceutical Parameters to Consider in Order to Alter The Fate of Nanocarriers After Oral Delivery

Roger, E., Lagarce, F., Garcion, E., & Benoît, J. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 332

Fate of polymeric nanocarriers for oral drug delivery

Plapied, L., Duhem, N., Rieux, A. D., & Véronique Préat, A. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320

Intestinal permeability and its relevance for absorption and elimination

Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304

An update on oral drug delivery via intestinal lymphatic transport

Zhang, Z., Lü, Y., Qi, J., & Wu, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.022 · Cited by 250

Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic

Maher, S., Leonard, T. W., Jacobsen, J. B., & Brayden, D. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.006 · Cited by 231

Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems

Xu, Y., Shrestha, N., Véronique Préat, A., & Beloqui, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.006 · Cited by 219

Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1

Batbayar, S., Lee, D.-H., & Kim, H.-W. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.5.433 · Cited by 206

Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination

Slütter, B., Plapied, L., Fievez, V., Alonso, M. J., Rieux, A. D., Schneider, Y., van Riet, E., Jiskoot, W., & Véronique Préat, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.011 · Cited by 192

Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells

Azizi, A., Kumar, A., Diaz-Mitoma, F., & Mestecky, J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001147 · Cited by 180

Biodegradable polymers in drug delivery and oral vaccination

Jana, P., Shyam, M., Singh, S., Jayaprakash, V., & Dev, A. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.110155 · Cited by 180

A novel M cell–specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

Nochi, T., Yuki, Y., Matsumura, A., Mejima, M., Terahara, K., Kim, D. Y., Fukuyama, S., Iwatsuki‐Horimoto, K., Kawaoka, Y., Kohda, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070607 · Cited by 177

Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome

Lee, Y., Kamada, N., & Moon, J. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114021 · Cited by 169

Cyclodextrin nanosystems in oral drug delivery: A mini review

Adeoye, O., & Cabral-Marques, H. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.050 · Cited by 159

Progress in the design and development of “fast-dissolving” electrospun nanofibers based drug delivery systems - A systematic review

Balusamy, B., Çelebioğlu, A., Anitha, S., & Uyar, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.038 · Cited by 162

Oral delivery of nanoparticle-based vaccines

Marasini, N., Skwarczyński, M., & Tóth, I. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.936852 · Cited by 157

Animal data: The contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo☆

Lennernäs, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.016 · Cited by 158

Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery

Ofokansi, K. C., Winter, G., Fricker, G., & Coester, C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.04.008 · Cited by 149

Targeted nanoparticles with novel non-peptidic ligands for oral delivery

Rieux, A. D., Pourcelle, V., Cani, P. D., Marchand‐Brynaert, J., & Véronique Préat, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.002 · Cited by 149

Advances in oral absorption of polysaccharides: Mechanism, affecting factors, and improvement strategies

Zheng, Z., Pan, X., Luo, L., Zhang, Q., Huang, X., Liu, Y., Wang, K., & Zhang, Y. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119110 · Cited by 146

The M Cell-Targeting Ligand Promotes Antigen Delivery and Induces Antigen-Specific Immune Responses in Mucosal Vaccination

Kim, S., Seo, K.-W., Kim, J., Lee, K., & Jang, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903184 · Cited by 134

Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation

Zheng, Y., Luo, S., Xu, M., He, Q., Xie, J., Wu, J., & Huang, Y. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.06.015 · Cited by 140

Transplacental transport of nanomaterials

Saunders, M. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.53 · Cited by 120

Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells

Primard, C., Rochereau, N., Luciani, E., Genin, C., Delair, T., Paul, S., & Verrier, B. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.021 · Cited by 112

Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles

Mady, F. M., & Shaker, M. A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s147740 · Cited by 111

Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

Criscuolo, E., Caputo, V., Diotti, R. A., Sautto, G. A., Kirchenbaum, G. A., & Clementi, N. (2019) · Journal of Immunology Research · doi:10.1155/2019/8303648 · Cited by 110

Mucosal vaccines: novel advances in technology and delivery

Yuki, Y., & Kiyono, H. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.61 · Cited by 109

Transport of chitosan–DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes

Kadiyala, I., Loo, Y., Roy, K., Rice, J., & Leong, K. W. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.002 · Cited by 109

Bilosomes in the context of oral immunization: development, challenges and opportunities

Shukla, A., Mishra, V. K., & Kesharwani, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.03.013 · Cited by 108

Towards tailored vaccine delivery: Needs, challenges and perspectives

Amorij, J., Kersten, G. F. A., Saluja, V., Tonnis, W. F., Hinrichs, W. L. J., Slütter, B., Bal, S. M., Bouwstra, J. A., Huckriede, A. L. W., & Jiskoot, W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.039 · Cited by 102

A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation

Beloqui, A., Brayden, D. J., Artursson, P., Véronique Préat, A., & Rieux, A. D. (2017) · Nature Protocols · doi:10.1038/nprot.2017.041 · Cited by 100

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases

Jazayeri, S. D., Lim, H. X., Shameli, K., Yeap, S. K., & Poh, C. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.682286 · Cited by 100

Role of intestinal microecology in the regulation of energy metabolism by dietary polyphenols and their metabolites

Lin, S., Wang, Z., Lam, K., Zeng, S., Tan, B. K., & Hu, J. (2019) · Food & Nutrition Research · doi:10.29219/fnr.v63.1518 · Cited by 96

Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?

Geller, A. E., & Yan, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01782 · Cited by 93

Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery

Devriendt, B., Geest, B. G. D., Goddeeris, B. M., & Cox, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.006 · Cited by 94

Impact of low and high molecular weight oat beta-glucan on oxidative stress and antioxidant defense in spleen of rats with LPS induced enteritis

Błaszczyk, K., Wilczak, J., Harasym, J., Gudej, S., Suchecka, D., Królikowski, T., Lange, E., & Gromadzka-Ostrowska, J. (2015) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2015.05.025 · Cited by 93

Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption

Fu, Q., Sun, J., Ai, X., Zhang, P., Li, M., Wang, Y., Liu, X., Sun, Y. H., Sui, X., Sun, L., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.065 · Cited by 91

Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations

Bal, S. M., Slütter, B., van Riet, E., Kruithof, A. C., Ding, Z., Kersten, G. F. A., Jiskoot, W., & Bouwstra, J. A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.018 · Cited by 89

Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting

Kang, S. H., Hong, S. J., Lee, Y.-K., & Cho, S. (2018) · Polymers · doi:10.3390/polym10090948 · Cited by 86

Engineering Nano‐ and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport

Miao, Y., Lin, Y., Chen, K., Luo, P.-K., Chuang, S., Yu, Y., Tai, H., Chen, C., Lin, K., & Sung, H. (2021) · Advanced Materials · doi:10.1002/adma.202104139 · Cited by 87

Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination

Slütter, B., & Jiskoot, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.009 · Cited by 86

Role of Microbiota in Sexually Dimorphic Immunity

Elderman, M. E., de Vos, P., & Faas, M. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01018 · Cited by 90

Innovative bioinformatic approaches for developing peptide‐based vaccines against hypervariable viruses

Sirskyj, D., Díaz‐Mitoma, F., Golshani, A., Kumar, A., & Azizi, A. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.65 · Cited by 80

Influence of Particle Geometry on Gastrointestinal Transit and Absorption following Oral Administration

Li, D., Zhuang, J., He, H., Jiang, S., Banerjee, A., Lü, Y., Wu, W., Mitragotri, S., Gan, L., & Qi, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11821 · Cited by 79

β‐glucan as a new tool in vaccine development

Větvička, V., Vannucci, L. E., & Šíma, P. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12833 · Cited by 78

Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization

Gupta, P. N., & Vyas, S. P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.08.027 · Cited by 78

Ligand-mediated active targeting for enhanced oral absorption

Zhang, X., & Wu, W. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.001 · Cited by 78

Implication of nanoparticles/microparticles in mucosal vaccine delivery

Vyas, S. P., & Gupta, P. N. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.401 · Cited by 76

Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies

Xie, Y., Shi, B., Xia, F., Qi, J., Dong, X., Zhao, W., Li, T., Wu, W., & Lü, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.046 · Cited by 75

Salmonella translocates across an in vitro M cell model independently of SPI-1 and SPI-2

Martínez‐Argudo, I., & Jepson, M. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/021162-0 · Cited by 68

Structural Constraints for the Binding of Short Peptides to Claudin-4 Revealed by Surface Plasmon Resonance

Ling, J., Liao, H., Clark, R. T., Wong, M. S. M., & Lo, D. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803548200 · Cited by 66

Evaluation of nanoparticle-encapsulated outer membrane proteins for the control of Campylobacter jejuni colonization in chickens

Annamalai, T., Pina-Mimbela, R., Kumar, A., Binjawadagi, B., Liu, Z., Renukaradhya, G. J., & Rajashekara, G. (2013) · Poultry Science · doi:10.3382/ps.2012-03004 · Cited by 65

Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation

Zhou, X., Wu, H., Long, R., Wang, S., Huang, H., Xia, Y., Wang, P., Lei, Y., Cai, Y., Cai, D., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00652-z · Cited by 64

Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts

Kanagaraj, A., Verma, D., & Daniell, H. (2011) · Plant Molecular Biology · doi:10.1007/s11103-011-9766-0 · Cited by 64

Analysis of Interactions of Salmonella Type Three Secretion Mutants with 3-D Intestinal Epithelial Cells

Radtke, A. L., Wilson, J. W., Sarker, S. F., & Nickerson, C. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015750 · Cited by 64

Nanocompounds of iron and zinc: their potential in nutrition

Zimmermann, M. B., & Hilty, F. M. (2011) · Nanoscale · doi:10.1039/c0nr00858c · Cited by 64

Tracking translocation of glucan microparticles targeting M cells: implications for oral drug delivery

Xie, Y., Hu, X., He, H., Xia, F., Ma, Y., Qi, J., Dong, X., Zhao, W., Lü, Y., & Wu, W. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02706c · Cited by 59

Nanoparticle oral absorption and its clinical translational potential

Kim, K. S., Na, K., & Bae, Y. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.024 · Cited by 59

Lipid coated mesoporous silica nanoparticles as an oral delivery system for targeting and treatment of intravacuolar Salmonella infections

Mudakavi, R. J., Raichur, A. M., & Chakravortty, D. (2014) · RSC Advances · doi:10.1039/c4ra12973c · Cited by 54

M cell-targeted delivery of vaccines and therapeutics

KuoLee, R., & Chen, W. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.693 · Cited by 57

In vitro identification of targeting ligands of human M cells by phage display

Fiévez, V., Plapied, L., Plaideau, C., Legendre, D., Rieux, A. D., Pourcelle, V., Freichels, H., Jérôme, C., Marchand, J., Véronique Préat, A., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.023 · Cited by 53

Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system

Martínez‐Argudo, I., Sands, C. J., & Jepson, M. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00891.x · Cited by 52

Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery

Plapied, L., Vandermeulen, G., Vroman, B., Véronique Préat, A., & Rieux, A. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.041 · Cited by 51

Dietary (1→3), (1→4)-β-d-glucans from oat activate nuclear factor-κB in intestinal leukocytes and enterocytes from mice

Volman, J. J., Mensink, R. P., Ramakers, J. D., de Winther, M. P. J., Carlsen, H., Blomhoff, R., Buurman, W. A., & Plat, J. (2010) · Nutrition Research · doi:10.1016/j.nutres.2009.10.023 · Cited by 51

Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers

Mishra, N., Goyal, A. K., Tiwari, S., Paliwal, R., Paliwal, S. R., Vaidya, B., Mangal, S., Gupta, M., Dube, D., Mehta, A., et al. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003730425 · Cited by 52

An in vitro cell-culture model demonstrates internalin- and hemolysin-independent translocation of Listeria monocytogenes across M cells

Corr, S. C., Hill, C., & Gahan, C. G. M. (2006) · Microbial Pathogenesis · doi:10.1016/j.micpath.2006.08.003 · Cited by 50

Bilosomes: Superior Vesicular Carriers

Palekar-Shanbhag, P., Lande, S., Chandra, R., & Rane, D. (2019) · Current Drug Therapy · doi:10.2174/1574885514666190917145510 · Cited by 49

Challenges and opportunities in delivering oral peptides and proteins

Peng, H., Wang, J., Chen, J., Peng, Y., Wang, X., Chen, Y., Kaplan, D. L., & Wang, Q. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2237408 · Cited by 52

Oral immunization with aLactobacillus casei-based anti-porcine epidemic diarrhoea virus (PEDV) vaccine expressing microfold cell-targeting peptide Co1 fused with the COE antigen of PEDV

Wang, X., Wang, L., Zheng, D., Chen, S., Shi, W., Qiao, X., Jiang, Y., Tang, L., Xu, Y., & Li, Y. J. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13652 · Cited by 46

Receptor mediated targeting of M-cells

Tyrer, P. C., Foxwell, A. R., Kyd, J. M., Otczyk, D. C., & Cripps, A. W. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.028 · Cited by 44

Using 3D gastrointestinal tract in vitro models with microfold cells and mucus secreting ability to assess the hazard of copper oxide nanomaterials

Ude, V. C., Brown, D. M., Stone, V., & Johnston, H. J. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0503-1 · Cited by 44

Exploiting or overcoming the dome trap for enhanced oral immunization and drug delivery

Qi, J., Zhuang, J., Lv, Y., Lü, Y., & Wu, W. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.021 · Cited by 43

Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route

Xia, F., Chen, Z., Zhu, Q., Qi, J., Dong, X., Zhao, W., Wu, W., & Lü, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.006 · Cited by 43

Oral Gavage Delivery of PR8 Antigen with β-Glucan-Conjugated GRGDS Carrier to Enhance M-Cell Targeting Ability and Induce Immunity

Lee, D.-Y., Nurunnabi, M., Kang, S. H., Nafiujjaman, M., Huh, K. M., Lee, Y.-K., & Kim, Y. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01855 · Cited by 42

The stomach, small intestine, and colon-specific gastrointestinal tract delivery systems for bioactive nutrients

Liang, S., Zhao, D., Liu, X., Liu, B., & Li, Y. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103503 · Cited by 41

Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles

Shaker, M. A., Elbadawy, H. M., Thagfan, S. S. A., & Shaker, M. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120077 · Cited by 41

The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration

Yang, X., Chen, X., Lei, T., Qin, L., Zhou, Y., Hu, C., Liu, Q., & Gao, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.011 · Cited by 40

Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy

Miao, Y., Xu, T., Gong, Y., Chen, A., Zou, L., Jiang, T., & Shi, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01991-3 · Cited by 43

Preliminary studies on the development of IgA-loaded chitosan–dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens

Sharma, S., Benson, H. A., Mukkur, T. K. S., Rigby, P. J., & Chen, Y. (2012) · Journal of Microencapsulation · doi:10.3109/02652048.2012.726279 · Cited by 39

Oral delivery of protein-based therapeutics: Gastroprotective strategies, physiological barriers and in vitro permeability prediction

Wright, L., Barnes, T. J., & Prestidge, C. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119488 · Cited by 39

Improving Oral Delivery

Gabor, F., Fillafer, C., Neutsch, L., Ratzinger, G., & Wirth, M. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_12 · Cited by 40

Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells

Liang, Y., Hastürk, H., Elliot, J., Noronha, A. M., Liu, X., Wetzler, L. M., Massari, P., Kantarcı, A., Winter, H. S., & Farraye, F. A. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.09.003 · Cited by 38

Artemisia argyi extract alleviates inflammation in a DSS-induced colitis mouse model and enhances immunomodulatory effects in lymphoid tissues

Shin, J. M., Son, Y., Ha, I. J., Erdenebileg, S., Jung, D. S., Song, D., Kim, Y. S., Kim, S. M., & Nho, C. W. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03536-x · Cited by 36

BILOSOME: A BILE SALT BASED NOVEL CARRIER SYSTEM GAINING INTEREST IN PHARMACEUTICAL RESEARCH

Rajput, T., & Chauhan, M. K. (2017) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v7i5.1479 · Cited by 34

Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases

Sun, T., Xue, M., Yang, J., Pei, Z., Zhang, N., Qin, K., & Liang, H. W. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11202 · Cited by 35

Recent advances in nano/microparticle-based oral vaccines

Li, M., Kaminskas, L. M., & Marasini, N. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00537-9 · Cited by 34

Formulation Design Considerations for Oral Vaccines

Wilkhu, J. S., McNeil, S. E., Kirby, D. J., & Perrie, Y. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.82 · Cited by 33

The third dimension: new developments in cell culture models for colorectal research

Pereira, J., Awatade, N. T., Loureiro, C. A., Matos, P., Amaral, M. D., & Jordan, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2258-2 · Cited by 32

β-Glucan successfully stimulated the immune system in different jawed vertebrate species

de Oliveira, C. A. F., Větvička, V., & Zanuzzo, F. S. (2018) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2018.11.006 · Cited by 32

Adhesion of Enteropathogenic, Enterotoxigenic, and Commensal Escherichia coli to the Major Zymogen Granule Membrane Glycoprotein 2

Bartlitz, C., Kolenda, R., Chilimoniuk, J., Grzymajło, K., Rödiger, S., Bauerfeind, R., Ali, A., Tchesnokova, V. L., Roggenbuck, D., & Schierack, P. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.02279-21 · Cited by 29

M cell: intestinal immunity’s gateway

Tran‐Van, H., Le-Dao, H.-A., & Dinh, T. M. (2021) · Science and Technology Development Journal - Natural Sciences · doi:10.32508/stdjns.v5i4.1111

M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis

Corr, S. C., Gahan, C. C. G. M., & Hill, C. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00359.x · Cited by 320

Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery

Brayden, D. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.036 · Cited by 43

Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells

Azizi, A., Kumar, A., Diaz-Mitoma, F., & Mestecky, J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001147 · Cited by 180

Functional differences between M cells and enterocytes in sampling luminal antigens

Kyd, J. M., & Cripps, A. W. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.061 · Cited by 75